Related Experiment Video
Updated: Aug 24, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Myosin binding protein C: structural abnormalities in familial hypertrophic cardiomyopathy
Cecily E Oakley1, Brett D Hambly, Paul M G Curmi
1Department of Pathology, University of Sydney, NSW 2006, Australia. cecily@med.usyd.edu.au
Insights
Myosin binding protein C (MyBPC) mutations are linked to familial hypertrophic cardiomyopathy (FHC). Analyzing MyBPC structure and FHC mutations may reveal disease mechanisms and protein functions in muscle contraction.
Area of Science:
- Muscle biology
- Cardiovascular research
- Protein structure and function
Background:
- Myosin binding protein C (MyBPC) is a key sarcomeric protein with a complex, incompletely understood role.
- Mutations in MyBPC are a significant cause of familial hypertrophic cardiomyopathy (FHC).
- While some MyBPC functions are known, its interactions with myosin, actin, and titin, and its assembly in the sarcomere, require further investigation.
Purpose of the Study:
- To review current literature on MyBPC structure, function, and interactions.
- To analyze MyBPC sequence in relation to FHC-causing mutations.
- To elucidate how MyBPC mutations contribute to the pathogenesis of FHC.
Main Methods:
- Literature review of MyBPC research.
- Sequence analysis of MyBPC domains.
- Comparison of MyBPC sequence with FHC mutation data.
- Examination of existing structural models of MyBPC.
Main Results:
- Identified specific MyBPC residues and regions potentially critical for binding or regulation.
- Correlated MyBPC structural features with FHC-associated mutations.
- Provided insights into the functional significance of MyBPC domains.
Conclusions:
- MyBPC's multi-domain structure, including immunoglobulin and fibronectin domains, is crucial for its function.
- Analysis of FHC mutations within the MyBPC sequence can illuminate disease mechanisms.
- Understanding MyBPC's interactions and assembly is vital for comprehending muscle contraction and FHC.
Abstract:
The muscle protein myosin binding protein C (MyBPC) is a large multi-domain protein whose role in the sarcomere is complex and not yet fully understood. Mutations in MyBPC are strongly associated with the heart disease familial hypertrophic cardiomyopathy (FHC) and these experiments of nature have provided some insight into the intricate workings of this protein in the heart. While some regions of the MyBPC molecule have been assigned a function in the regulation of muscle contraction, the interaction of other regions with various parts of the myosin molecule and the sarcomeric proteins, actin and titin, remain obscure. In addition, several intra-domain interactions between adjacent MyBPC molecules have been identified. Although the basic structure of the molecule (a series of immunoglobulin and fibronectin domains) has been elucidated, the assembly of MyBPC in the sarcomere is a topic for debate. By analysing the MyBPC sequence with respect to FHC-causing mutations it is possible to identify individual residues or regions of each domain that may be important either for binding or regulation. This review looks at the current literature, in concert with alignments and the structural models of MyBPC, in an attempt to understand how FHC mutations may lead to the disease state.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Overview of Myosin Structure and Function
The Sarcomere
Each myosin...
Actin and Myosin in Muscle Contraction
Cardiomyopathy II: Dilated Cardiomyopathy
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...

